Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11032 results:
[ Συντάκτης(Desc)] Τίτλος Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
Sarafidis, P. A., & Tsapas A. (2016).  Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.. N Engl J Med. 374(11), 1092.
Sarafidis, P. A., Loutradis C., Karpetas A., Tzanis G., Bikos A., Raptis V., et al. (2019).  The association of interdialytic blood pressure variability with cardiovascular events and all-cause mortality in haemodialysis patients.. Nephrol Dial Transplant. 34(3), 515-523.
Sarafidis, P. A., & Bakris G. L. (2014).  Early patterns of blood pressure change and future coronary atherosclerosis.. JAMA. 311(5), 471-2.
Sarafidis, P. A., Lazaridis A. A., Ruiz-Hurtado G., & Ruilope L. M. (2017).  Blood pressure reduction in diabetes: lessons from ACCORD, SPRINT and EMPA-REG OUTCOME.. Nat Rev Endocrinol. 13(6), 365-374.
Sarafidis, P. A., Memmos E., Alexandrou M-E., & Papagianni A. (2018).  Mineralocorticoid Receptor Antagonists for Nephroprotection: Current Evidence and Future Perspectives.. Curr Pharm Des. 24(46), 5528-5536.
Sarafidis, P. A., Georgianos P. I., & Lasaridis A. N. (2010).  Diuretics in clinical practice. Part II: electrolyte and acid-base disorders complicating diuretic therapy.. Expert Opin Drug Saf. 9(2), 259-73.
Sarafidis, P. A., & Ruilope L. M. (2013).  Renin-angiotensin-aldosterone system blockade in hypertensive patients with chronic kidney disease.. Blood Press. 22(6), 397-8.
Sarafidis, K., Soubasi-Griva V., Piretzi K., Thomaidou A., Agakidou E., Taparkou A., et al. (2010).  Diagnostic utility of elevated serum soluble triggering receptor expressed on myeloid cells (sTREM)-1 in infected neonates.. Intensive Care Med. 36(5), 864-8.
Sarafidis, P., & Papagianni A. (2019).  Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections.. Ann Intern Med. 171(12), 943-944.
Sarafidis, K., Tsepkentzi E., Diamanti E., Agakidou E., Taparkou A., Soubasi V., et al. (2014).  Urine neutrophil gelatinase-associated lipocalin to predict acute kidney injury in preterm neonates. A pilot study.. Pediatr Nephrol. 29(2), 305-10.
Sarafidis, P. A., Ruilope L. M., Loutradis C., Gorostidi M., de la Sierra A., de la Cruz J. J., et al. (2018).  Blood pressure variability increases with advancing chronic kidney disease stage: a cross-sectional analysis of 16 546 hypertensive patients.. J Hypertens. 36(5), 1076-1085.
Sarafidis, P. A., & Lasaridis A. N. (2010).  Diabetic nephropathy: Endothelin antagonism for diabetic nephropathy.. Nat Rev Nephrol. 6(8), 447-9.
Sarafidis, P., & Bakris G. (2020).  Diastolic Blood Pressure Does Not Influence Cardiovascular Outcomes in Type 2 Diabetes; or Does It?. Diabetes Care. 43(8), 1684-1686.
Sarafidis, K., Begou O., Deda O., Gika H., Agakidis C., Efstathiou N., et al. (2019).  Targeted urine metabolomics in preterm neonates with intraventricular hemorrhage.. J Chromatogr B Analyt Technol Biomed Life Sci. 1104, 240-248.
Sarafidis, P. A. (2011).  Epidemiology of resistant hypertension.. J Clin Hypertens (Greenwich). 13(7), 523-8.
Sarafidis, P. A. (2017).  Online Hemodiafiltration Improves Outcomes in Incident Patients with End-Stage Renal Disease: Another Brick in the Wall?. Am J Nephrol. 46(4), 285-287.
Sarafidis, P. A., Kamperidis V., Loutradis C., Tsilonis K., Mpoutsiouki F., Saratzis A., et al. (2017).  Haemodialysis acutely deteriorates left and right diastolic function and myocardial performance: an effect related to high ultrafiltration volumes?. Nephrol Dial Transplant. 32(8), 1402-1409.
Sarafidis, K., Stathopoulou T., Agakidou E., Taparkou A., Soubasi V., Diamanti E., et al. (2011).  Comparable effect of conventional ventilation versus early high-frequency oscillation on serum CC16 and IL-6 levels in preterm neonates.. J Perinatol. 31(2), 104-11.
Sarafidis, P. A., & Ortiz A. (2020).  The risk for urinary tract infections with sodium-glucose cotransporter 2 inhibitors: no longer a cause of concern?. Clin Kidney J. 13(1), 24-26.
Sarafidis, P. A., & Ruilope L. M. (2013).  Blood pressure targets for patients with chronic kidney disease.. Blood Press. 22(6), 395-6.
Sarafidis, K., Iosifidis E., Gikas E., Tsivitanidou M., Drossou-Agakidou V., & Roilides E. (2010).  Daptomycin use in a neonate: serum level monitoring and outcome.. Am J Perinatol. 27(5), 421-4.
Sarafidis, P., Loutradis C., Ferro C. J., & Ortiz A. (2020).  SGLT-2 Inhibitors to Treat Hyponatremia Associated with SIADH: A Novel Indication?. Am J Nephrol. 51(7), 553-555.
Sarafidis, P. A., Georgianos P. I., Germanidis G., Giavroglou C., Nikolaidis P., Lasaridis A. N., et al. (2012).  Hypertension and symptomatic hypokalemia in a patient with simultaneous unilateral stenoses of intrarenal arteries and mesangioproliferative glomerulonephritis.. Am J Kidney Dis. 59(3), 434-8.
Sarafidis, P. A., Mallamaci F., Loutradis C., Ekart R., Torino C., Karpetas A., et al. (2018).  Prevalence and control of hypertension by 48-h ambulatory blood pressure monitoring in haemodialysis patients: a study by the European Cardiovascular and Renal Medicine (EURECA-m) working group of the ERA-EDTA.. Nephrol Dial Transplant. 33(10), 1872.
Sarafidis, P., Loutradis C., Ortiz A., & Ruilope L. M. (2020).  Blood pressure targets in patients with chronic kidney disease: MDRD and AASK now confirming SPRINT.. Clin Kidney J. 13(3), 287-290.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές